terminal betA novel, weak bromo and extra terminal domain (BET) bromodomain fragment land to a potent and selective second bromodomain (BD2) inhibitor.The BET family controls the transcription of a wide range of proinflammatory and immunoregulatory genes by recognizing acetylated histones (mainly H3 and